U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254052) titled 'Effectiveness of Ammonium Chloride in Reducing Viral Load' on Nov. 19.
Brief Summary: This is a prospective, double-blind, randomized, comparative effectiveness pilot study evaluating the effect of a sustained-release ammonium chloride formulation (ACF) on viral load dynamics in adult patients with mild or moderate COVID-19 or seasonal influenza infection.
Eligible participants are randomly assigned in a 1:1 ratio to receive either ACF (ammonium chloride with vitamin D) or a control formulation (vitamin D only) twice daily for 10 consecutive days. The primary objective is to assess the reduction of viral load measured by RT-PCR cyc...